Skip to main content

Safety and Clinical Outcomes of an Equine-Derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States

Submitted by lsekela on June 19, 2019 - 08:59 AM

 Treatment with BAT® [Botulism Antitoxin Heptavalent (Equine)] was associated with shorter hospital and intensive care unit stays.

Content Source:

Clinical Infectious Diseases

Content Author:

Jason S Richardson, Geraldine S Parrera, Hugo Astacio

Tags: